Publication of the 2nd Regulation on CMRs
Add to my portfolio
pro subscription only feature
see our subscription plans
While their first start was a bit slow, the CMR Omnibus now looks like a moving train. Scheduled to arrive each year, in order to transcribe the recent harmonised classifications of substances into the Cosmetics Regulation, they are well on track. The second has just been published in the Official Journal of the European Union on 25 November 2019, with just a few adaptations compared to the text notified to the WTO last June.
After the publication of the first Omnibus text on CMRs, Regulation 2019/831, in May 2019, this Regulation 2019/1966 deals with substances classified as CMRs by Regulation 2018/1480, which will be applicable from 1 May 2020.
Key points of Regulation 2019/1966
• An exemption from the prohibition is granted for salicylic acid and its salts, despite the classification in CMR 2, but its conditions of use are significantly restricted.
• As no other substances classified as CMR by Regulation 2018/1480 have been requested for use, they are all added to Annex II (Prohibited Substances) of Cosmetics Regulation 1223/2009 if they are not already included.
• 19 CMR substances that had been forgotten in the first Omnibus Regulation are also added to Annex II of the Cosmetics Regulation. • The text is applicable from 1 May 2020, with the exception of two corrections (for Oxyquinoline sulphate) which apply from 11 June 2019.
The “Whereas” of Regulation 2019/1966
Regulation (EC) No.1272/2008 of the European Parliament and of the Council provides for a harmonised classification of substances as carcinogenic, mutagenic or toxic for reproduction (CMR) based on a scientific assessment by the Risk Assessment Committee of the European Chemicals Agency. The substances are classified as CMR substances of category 1A, CMR substances of category 1B or CMR substances of category 2 depending on the level of evidence of their CMR properties. ...